• Exchange: Frankfurt
  • Sector: Health Care
  • Industry: Biotech & Pharma
  • Sub-Industry: Generic Pharmaceuticals

Impax Laboratories Inc

+ Add to Watchlist

ILR:GR

20.765 EUR 0.411 1.94%

As of 09:37:16 ET on 07/25/2014.

Snapshot for Impax Laboratories Inc (ILR)

Open: 20.515 Day's Range: 20.515 - 20.920 Volume: 0
Previous Close: 21.176 52wk Range: 14.050 - 22.900 1-Yr Rtn: +33.37%

Stock Chart for ILR

No chart data available.
  • ILR:GR 20.765
  • 1D
  • 1M
  • 1Y
21.176
Interactive ILR Chart

Previous Close

No chart data available.
Interactive Chart
  • 1D
  • 1W
  • 1M
  • YTD
  • 1Y
  • 3Y
  • 5Y
Close:
Open:
High:
Low:
Volume:
Recently Viewed Symbols
Save as Watchlist
Saving as watchlist...

Key Statistics for ILR

Current P/E Ratio (ttm) -
Estimated P/E(12/2014) 30.7446
Relative P/E vs. DAX -
Earnings Per Share (USD) (ttm) -
Est. EPS (USD) (12/2014) 0.9070
Est. PEG Ratio 1.0573
Market Cap (M EUR) 1,454.73
Shares Outstanding (M) 70.06
30 Day Average Volume 9
Price/Book (mrq) -
Price/Sale (ttm) -
Dividend Indicated Gross Yield -%
Cash Dividend -
Dividend Ex-Date
5 Year Dividend Growth -
Next Earnings Announcement 08/06/2014
mrq = Most Recent Quarter; ttm = Trailing Twelve Months

Income Statement for ILR

  • Revenue
  • Net Income (M/USD)
  • Profit Margin (%)

Company Profile & Key Executives for ILR

Impax Laboratories, Inc. develops, manufactures, and markets both proprietary and multi-source pharmaceutical products utilizing its drug delivery technologies. The Company specializes in the development of niche and controlled release generics, as well as the development of branded products.

George Frederick Wilkinson "Fred"President/CEOCarole S Ben-MaimonPres:Global Pharmaceuticals
Michael J NestorPres:Impax PharmaceuticalsBryan M ReasonsSenior VP:Finance/CFO
More Company Profile & Key Executives for ILR

Quotes delayed, except where indicated otherwise. All prices in local currency. Time is ET.

Sponsored Link
Advertisement
Advertisement
Sponsored Links
Advertisements
sec ||= nil